In conjunction with other report that highlights PAK1 overexpression in squamous cell NSCLC [25], [46], it seems PAK1 inhibition might provide a viable strategy in order to interrupt the pro-metastatic behavior of certain NSCLC subtypes. The gene discussed is PAK1; the disease is non-small cell lung carcinoma.